DRUG · Unmapped registry intervention
BMS-986500
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
NCT06997029
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Palbociclib
Normalized identity: palbociclibView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Fulvestrant
Normalized identity: fulvestrantView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
BMS-986500DRUG
PalbociclibDRUG · verified · RxNorm: palbociclib
FulvestrantDRUG · verified · RxNorm: fulvestrant
Sponsors & collaborators
Bristol-Myers Squibblead sponsor
Mapped research locations
New YorkNew York, United States2BostonMassachusetts, United States1St LouisMissouri, United States1San AntonioTexas, United States1BirminghamAlabama, United States1AuroraColorado, United States1La JollaCalifornia, United States1BuffaloNew York, United States1Fort WorthTexas, United States1CopenhagenDenmark1LebanonNew Hampshire, United States1Newport BeachCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06997029 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.